Startseite Assessment of hearing in children with type 1 diabetes mellitus
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Assessment of hearing in children with type 1 diabetes mellitus

  • Soha M. Abd El Dayem EMAIL logo , Somaya M. Abd El Ghany , Amal E. Beshr , Amal G. Hassan und Mona S. Attaya
Veröffentlicht/Copyright: 27. Februar 2014

Abstract

Objective: To evaluate auditory function in a group of Egyptian type 1 diabetic children.

Methods: This was a cross sectional observational study, which included 40 patients with type 1 diabetes and 40 controls. HbA1, urinary albumin/creatinine ratio, and auditory assessments (including dizziness questionnaire, pure tone audiometry, speech audiometry, tympanometry, and auto-acoustic cochlear emission) were completed for all patients and controls. Mann-Whitney U-test, χ2-test and Spearman’s correlation were used for statistical analyses.

Results: Assessment of pure tone audiometry revealed that the diabetics had a significantly higher reading in high frequency at 8000 Hz, 16,000 Hz, 17,000 Hz, and 18,000 Hz on the right side and at 4000 Hz, 8000 Hz, 16,000 Hz, 17,000 Hz, and 18,000 Hz on the left side. There was a significantly lower level in speech reception threshold, repetition of words, and masking level of diabetics on the left side. Evaluation of transient otoacoustic emission revealed that diabetics recorded significantly lower signal to noise ratio at 4000 Hz on the right side and at 1000, 1500, 4000, and all Hz on left side. There was significant lower emission amplitude in the right side of the diabetics group at 1500 and 4000 Hz and at 1000, 1500, and 4000 Hz on the left side. Patients with failed otoacoustic emission were significantly higher in disease duration >10 years.

Conclusion: Type 1 diabetes is associated with high/extended high frequency hearing loss, more prominent on the left side and with longer disease duration.


Corresponding author: Soha M. Abd El Dayem, Professor of Pediatrics, National Research Centre, Pediatrics Department, Cairo, Egypt, Phone: +2 01006716852, E-mail:

References

1. American Diabetes Association (ADA). Standards of medical care in diabetes. Diabetes Care 2011;34:S11–61.10.2337/dc11-S011Suche in Google Scholar

2. Katrena W. Hearing loss linked to diabetes for senior in home health and wellness. Senior Healthy Medication, 2011:1–5.Suche in Google Scholar

3. Fukushima H, Cureoglu S, Schachern PA, Paparella MM, Harada T, et al. Effects of type 2 diabetes mellitus on cochlear structure in humans. Arch Otolaryngol Head Neck Surg 2006;132:934–8.10.1001/archotol.132.9.934Suche in Google Scholar

4. Miller J, Beck L, Davis A, Jones DE, Thomas AB. Hearing loss in patients with diabetic retinopathy. Am J Otolaryngol 1983;4:342–6.10.1016/S0196-0709(83)80021-0Suche in Google Scholar

5. Makishima KT. Pathological changes of the inner ear and central auditory pathway in diabetics. Ann Otol Rhinol Laryngol 1971;80:218–28.10.1177/000348947108000208Suche in Google Scholar

6. Maia CA, Campos CA. Diabetes mellitus as etiological factor of hearing loss. Braz J Otorhino-laryngol 2005;71:208–14.10.1016/S1808-8694(15)31312-4Suche in Google Scholar

7. Lisowska G, Namyslowski G, Morawski K, Strojek K. Identification of hearing impairment in patients with type 1 diabetes mellitus. Otol Neurol 2001;22:316–20.10.1097/00129492-200105000-00008Suche in Google Scholar

8. Kluk K, Moore BC. Dead regions and enhancement of frequency discrimination: effects of audiogram slope, unilateral versus bilateral loss, and hearing-aid use. Hear Res 2006;222:1–15.10.1016/j.heares.2006.06.020Suche in Google Scholar

9. Debonis DA, Donohue CL. Survey of audiology fundamentals for audiologists and health professionals. 2nd ed. Boston: Allyn and Bacon, 2007.Suche in Google Scholar

10. Steele DJ, Susman J, McCurdy FA. Student guide to primary care: making the most of your early clinical experience. Philadelphia: Hanley & Belfus; Oxford: Elsevier Health Sciences, 2003. xvii, 392. http://trove.nla.gov.au/version/38833336, 2011:370.Suche in Google Scholar

11. Kemp DT. Stimulated acoustic emissions from within the human auditory system. J Acoust Soc Am 1978;64:1386–91.10.1121/1.382104Suche in Google Scholar

12. Muller HG, Hall JH. Audiologists’ desk reference, Vol. 1. San Diego, London: Singular Publishing Group, Inc., 1998:916.Suche in Google Scholar

13. Fowler CG, Shanks JE. Tympanometry. In: Katz J, Burkard RF, Medwetsky L, editors. Handbook of clinical audiology. 5th ed. Philadelphia: Lippincott Williams and Wilkins, 2002:175–204.Suche in Google Scholar

14. Dirks DD, Morgan DE. Tympanometry and acoustic reflex testing. In: Canalis RF, Lambert PR, editors. The ear: comprehensive otology. Philadelphia: Lippincott, Williams and Wilkins, 2000:223–9.Suche in Google Scholar

15. Pelton SI. Otitis media. In: Long SS, Pickering LK, Prober CG, editors. Principles and practice of pediatric infectious diseases. 2nd ed. New York: Churchill Livingstone, 2003:190–8.Suche in Google Scholar

16. Maxon AA, White K, Vohr B, Behrans T. Using transient evoked otoacoustic emission for neonatal hearing screening. Br J Audiol 1993;27:149–53.10.3109/03005369309077906Suche in Google Scholar

17. El Amin A, Fadlallah M, Tuvemo T. Hearing loss in children with type 1 diabetes. Indian Pediatr 2005;42:15–21.Suche in Google Scholar

18. Ferrer J, Biurrum O, Lorente J, Conget J, deEspaa R, et al. Auditory function in young patients with type 1 diabetes mellitus. Diabetes Res Clin Pract 1991;11:17–22.10.1016/0168-8227(91)90136-2Suche in Google Scholar

19. Kurien M, Thomas K, Bhanu TS. Hearing threshold in patients with diabetes mellitus. J Laryngol Otol 1989;103:164–8.10.1017/S0022215100108345Suche in Google Scholar

20. Poovazhagi V, Nagarajan M, Saradha S. Hearing loss in children with type 1 diabetes mellitus. Diabetic Clinic, Department of Pediatrics, Institute of Child Health and Hospital for Children, Egmore, Chennai, 2010:2–4.Suche in Google Scholar

21. Michels AW, Eisenbarth GS. Immune intervention in type 1 diabetes. Semin Immunol 2011;23:214–9.10.1016/j.smim.2011.07.003Suche in Google Scholar PubMed PubMed Central

22. Kariya S, Cureoglua S, Fukushimad H, Moritad N, Baylanc MY, et al. Comparing the cochlear spiral modiolarartery in type-1 and type-2 diabetes mellitus: a human temporal bone study. Acta Med Okayama 2010;64:375–83.Suche in Google Scholar

23. Fausti SA, Henry JA, Helt WJ, Phillips DS, Frey RH, et al. An individualized, sensitive frequency range for early detection of ototoxicity. Ear Hear 1999;20:497–505.10.1097/00003446-199912000-00005Suche in Google Scholar PubMed

24. Frank T. High frequency (8 to 16 KHz) reference thresholds and intrasubject threshold variability relative to ototoxicity criteria using Sennheiser HAD 200 earphones. Ear Hear 2001;22:161–8.10.1097/00003446-200104000-00009Suche in Google Scholar PubMed

25. Kuronen P, Sorri MJ, Pääkkönen R, Muhli A. Temporary threshold shift in military pilots measured using conventional and extended high-frequency audiometry after one flight. Int J Audiol 2003;42:29–33.10.3109/14992020309056082Suche in Google Scholar PubMed

26. Abdel-Maksoud AI. Extended high frequency audiometry and otoacoustic emissions in diabetic patients: a sensitivity study. Egypt J Otolaryngol 2003;20:303–13.Suche in Google Scholar

27. Maher SH, Abdel Kader MS, Mohamed N, Abdel Hai WE. Subclinical hearing deficits in patients with type 1 diabetes mellitus and its relation to microvascular complications. MSC degree in pediatrics 2007:133–50.Suche in Google Scholar

28. Osterhammel D, Christau B. High frequency audiometry and stapedius muscle reflex threshold in juvenile diabetics. Scand Audiol 1980;9:13–8.10.3109/01050398009076329Suche in Google Scholar PubMed

29. Siegger A, White NH, Skinner MW, Spector GJ. Auditory function in children with diabetes mellitus. Ann Otol Rhinol Laryngol 1983;92:237–41.10.1177/000348948309200305Suche in Google Scholar PubMed

30. Parving A, Elberling C, Balle V, Parbo J, Dejgard A, et al. Hearing disorders in patients with insulin-dependent diabetes mellitus. Audiology 1990;29:113–21.10.3109/00206099009072844Suche in Google Scholar PubMed

31. Margolis RH, Saly GL, Hunter LL. High-frequency hearing loss and wide band middle ear impedance in children with otitis media histories. Ear Hear 2000;21:206–11.10.1097/00003446-200006000-00003Suche in Google Scholar PubMed

32. Ear noise can be used as identification, 2009. www.telegraph.co.uk, available at www.wikipidia.com. Accessed 25 April, 2009.Suche in Google Scholar

33. Balatsouras DG, Kaberos A, Kloutsos G, Economou NC, Sakellariadis V, et al. Correlation of transiently evoked to distortion-product otoacoustic emission measures in healthy children. Int J Pediatr Otorhinolaryngol 2006;70:89–93.10.1016/j.ijporl.2005.05.022Suche in Google Scholar PubMed

34. Eiserman W, Shisler L. Identifying hearing loss in young children: technology replaces the bell. Zero Three 2010;30:24–8.Suche in Google Scholar

35. El-Danasoury IM, Abdel-Maksoud AI, Habib AM. Assessment of olivocochlear bundle in insulin-dependent diabetic children. Ain Shams Med J 2001;52:1337–50.Suche in Google Scholar

36. Ottiviani F, Dozio N, Neglia SB, Riccio S, Scavini M. Absence of otoacoustic emissions in insulin-dependent diabetic patients is there evidence of diabetic cochleopathy. J Diabet Complications 2002;16:338–43.10.1016/S1056-8727(01)00224-0Suche in Google Scholar

37. Acar M, Aycan Z, Acar B, Ertan U, Peltek HN, et al. Audiologic evaluation in pediatric patients with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2012;25:503–8.10.1515/jpem-2012-0062Suche in Google Scholar PubMed

38. Di Nardo W, Ghirlanda G, Paludetti G, Cercone S, Saponara C, et al. Distortion-product otoacoustic emissions and selective sensorineural loss in IDDM. Diabetes Care 1998;21:1317–21.10.2337/diacare.21.8.1317Suche in Google Scholar PubMed

39. Okhovat SA, Moaddab MH, Okhovat SH, Al-Azab AA, Saleh FA, et al. Evaluation of hearing loss in juvenile insulin dependent patients with diabetes mellitus. J Res Med Sci 2011;16: 179–83.Suche in Google Scholar

40. Kurien M, Thomas K, Bhanu TS. Hearing threshold in patients with evoked responses in insulin-dependent (ID) and non-insulin dependent (NID) diabetic subjects with normal hearing. Int J Audiol 2004;43:29–33.10.1080/14992020400050005Suche in Google Scholar PubMed

41. Virtaniemi J, Laasko M, Nuutien J, Karjalaninen S, Vartinainen E. Hearing thresholds in insulin-dependent diabetic patients. J Laryngo Otol 1994;108:837–41.10.1017/S0022215100128270Suche in Google Scholar PubMed

42. Kasemsuwan L, Sriwanyong S, Krittiyawong S, Sunetrworkau J, Jimsuchon K. Hearing in young diabetic patients. J Med Assoc Thai 2001;84:1389–94.Suche in Google Scholar

43. Karen JD, Yvonne S, Arnold S. Auditory neuropathy in childhood. Laryngoscope 1998;108:1374–7.10.1097/00005537-199809000-00022Suche in Google Scholar PubMed

44. Prieve BA. Otoacoustic emissions in infants and children; basic characteristics and clinical applications. Semin Hear 1992;13:37–52.10.1055/s-0028-1085140Suche in Google Scholar

45. Brook L, Trussell J, Hilton K, Forsyth H, Pizer B. Normal values for distortion product otoacoustic emissions in children: a study using primary levels previously demonstrated to be optimum for identification of hearing loss. Scand Audiol 2001;53:37–43.10.1080/010503901750166628Suche in Google Scholar PubMed

46. Vaughan N, James K, McDermott D, Gricot J, Fausti S. A 5-year prospective study of diabetes and hearing loss in a veteran population. Otol Neurotol 2006;27:37–43.10.1097/01.mao.0000194812.69556.74Suche in Google Scholar PubMed

47. Durmus C, Yetiser S, Durmus O. Auditory brainstem diabetes mellitus. J Laryngol Otol 2004;103:164–8.Suche in Google Scholar

48. Lin CH, Lee YJ, Huang CY, Shieh JW, Lin HC, et al. Wolfram (DIDMOAD) syndrome: report of two patients. J Pediatr Endocrinol Metab 2004;17:1461–4.10.1515/JPEM.2004.17.10.1461Suche in Google Scholar

Received: 2013-7-10
Accepted: 2013-12-27
Published Online: 2014-2-27
Published in Print: 2014-5-1

©2014 by Walter de Gruyter Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Original articles
  3. Assessment of hearing in children with type 1 diabetes mellitus
  4. Insulin resistance and lipid profiles in HIV-infected Thai children receiving lopinavir/ritonavir-based highly active antiretroviral therapy
  5. Increased hunger and speed of eating in obese children and adolescents
  6. Glucagon and insulin cord blood levels in very preterm, late preterm and full-term infants
  7. Thyroid function in late preterm infants in relation to mode of delivery and respiratory support
  8. Prevalence of vitamin D deficiency and its related factors in children and adolescents living in North Khorasan, Iran
  9. Asymmetric dimethyl L-arginine, nitric oxide and cardiovascular disease in adolescent type 1 diabetics
  10. A combined nutritional-behavioral-physical activity intervention for the treatment of childhood obesity – a 7-year summary
  11. The effect of earlier puberty on cardiometabolic risk factors in Afro-Caribbean children
  12. Prevalence of risk of deficiency and inadequacy of 25-hydroxyvitamin D in US children: NHANES 2003–2006
  13. Serum uric acid: relationships with biomarkers in adolescents and changes over 1 year
  14. Psychological impact on parents of children with congenital adrenal hyperplasia: a study from Sri Lanka
  15. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease
  16. Diseases accompanying congenital hypothyroidism
  17. Molecular diagnosis of a Chinese pedigree with α-mannosidosis and identification of a novel missense mutation
  18. Are the characteristics of thyroid cancer different in young patients?
  19. Unsaturated fatty acids and insulin resistance in childhood obesity
  20. Effect of genetic subtypes and growth hormone treatment on bone mineral density in Prader-Willi syndrome
  21. KCNJ11 gene mutation analysis on nine Chinese patients with type 1B diabetes diagnosed before 3 years of age
  22. Prevalence and risk factors of metabolic syndrome in school adolescents of northeast China
  23. Patient reports
  24. A novel activating ABCC8 mutation underlying neonatal diabetes mellitus in an infant presenting with cerebral sinovenous thrombosis
  25. Endocrinological anomalies in a patient with 12q14 microdeletion syndrome. Completing phenotype of this exceptional short stature condition
  26. Acute mental status change as the presenting feature of adrenal insufficiency in a patient with autoimmune polyglandular syndrome type II and stroke
  27. Effect of ethosuximide on cortisol metabolism in the treatment of congenital adrenal hyperplasia
  28. Absence of WNT4 gene mutation in a patient with MURCS association
  29. Identification of a novel insulin receptor gene heterozygous mutation in a patient with type A insulin resistance syndrome
  30. Adrenal insufficiency in association with congenital nephrotic syndrome: a case report
  31. Diabetic lipemia presenting as eruptive xanthomas in a child with autoimmune polyglandular syndrome type IIIa
  32. A case report of nephrogenic diabetes insipidus with idiopathic Fanconi syndrome in a child who presented with vitamin D resistant rickets
  33. Letter to the Editor
  34. Hyperbilirubinemia in neonates of diabetic mothers: an indirect biomarker of organ damage?
Heruntergeladen am 24.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0287/html
Button zum nach oben scrollen